Status:
COMPLETED
Does the Relaxation Response Inhibit Acute Stress?
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Healthy
Eligibility:
All Genders
18-49 years
Phase:
PHASE2
Brief Summary
The purposes of this study are: 1. To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults. 2. To compar...
Detailed Description
The purposes of this study are: 1. To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults. 2. To compar...
Eligibility Criteria
Inclusion
- healthy individual
- age:18-49 years
- able to read and understand English
- able to attend al study visits
- access to a telephone (to schedule visits)
Exclusion
- current smoking
- asthma
- current use of any prescription or psychoactive medications or supplements
- either:
- no prior experience with RR eliciting techniques
- at least 3 years of regular RR elicitation (at least 20 min/day)
- BMI \>30
- exhaled nitric oxide levels \>60 ppb
- abnormal lab values (Hct \<32,creatinine \>1.3, glucose \>200
- pregnancy
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2011
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00179595
Start Date
May 1 2002
End Date
October 1 2011
Last Update
February 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth-Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215